Adaptive regulation of hepatocyte transporters in cholestasis

The Liver: Biology and Pathobiology

Volumn , Issue , 2009, Pages 681-702

  Boyer, James L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855921619     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747919.ch43     Document Type: Chapter

References (222)

1. Trauner, M. and Boyer, J.L. (2003) Bile salt transporters: molecular characterization, function and regulation. Physiol Rev, 83, 633-71.
2. Trauner, M., Wagner, M., Fickert, P. and Zollner, G. (2005) Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol, 39 (4, Suppl 2), 111-24.
3. Zollner, G. and Trauner, M. (2008) Mechanisms of cholestasis. Clin Liver Dis, 12 (1), 1-26, vii.
4. Stahl, S., Davies, M.R., Cook, D.I. and Graham, M.J. (2008) Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis. Xenobiotica, 38 (7), 725-77.
5. Geier, A., Wagner, M., Dietrich, C.G. and Trauner, M. (2007) Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta, 1773 (3), 283-308.
6. Boyer, J.L. (2007) New perspectives for the treatment of cholestasis: lessons from basic science applied clinically. J Hepatol, 46 (3), 365-71.
7. Vos, T.A., Hooiveld, G.J., Koning, H., Childs, S., Meijer, D.K., Moshage, H. et al. (1998) Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology, 28, 1637-44.
8. Schrenk, D., Gant, T.W., Preisegger, K.-H., Silverman, J.A., Marino, P.A. and Thorgeirsson, S.S. (1993) Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology, 17, 854-60.
9. Konig, J., Rost, D., Cui, Y. and Keppler, D. (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology, 29, 1156-63.
10. Soroka, C.J., Lee, J.M., Azzaroli, F. and Boyer, J.L. (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology, 33, 783-91.
11. Donner, M.G. and Keppler, D. (2001) Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology, 34, 351-59.
12. Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.-U., Zatloukal, K. et al. (2003) Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol, 38, 717-27.
13. Denk, G.U., Soroka, C.J., Takeyama, Y., Chen, W.S., Schuetz, J.D. and Boyer, J.L. (2004) Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol, 40 (4), 585-91.
14. Keitel, V., Burdelski, M., Waqrskulat, U., Kuhlkamp, T., Keppler, D., Haussinger, D. et al. (2005) Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology, 41, 1160-72.
15. Mennone, A., Soroka, C.J., Cai, S.Y., Harry, K., Adachi, M., Hagey, L. et al. (2006) Mrp4-/-mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology, 43 (5), 1013-21.
16. Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J. and Zatloukal, K. et al. (2007) Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int, 27 (7), 920-29.
17. Takeyama, Y., Uehara, Y., Inomata, S., Morihara, D., Nishizawa, S., Ueda, S.I. et al. (2009) Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis. Liver Int 29 (3), 406-14.
18. Boyer, J.L., Trauner, M., Mennone, A., Soroka, C.J., Cai, S.Y., Moustafa, T. et al. (2006) Up-regulation of a basolateral FXR-dependent bile acid efflux transporter, OSTα-OSTβ, in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol 290, G1124-30.
19. Kool, M., van der Linden, M., de Haas, M., Scheffer, G.L., de Vree, J.M.L., Smith, A.J. et al. (1999) MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A, 96 (12), 6914-19.
20. Hirohashi, T., Suzuki, H., Takikawa, H. and Sugiyama, Y. (2000) ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem, 275, 2905-10.
21. Boyer, J.L. (1996) Vanishing bile duct syndrome - from bench to bedside. In: Vanishing Bile Duct Syndrome -Pathophysiology and Treatment. International Falk Workshop, 30 May-1 June 1996. Kluwer Academic Publishers, Dordrecht, pp. 238-52.
22. Lazaridis, K.N., Pham, L., Tietz, P., Marinelli, R.A., de Groen, P.C., Levine, S. et al. (1997) Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest, 100, 2714-21.
23. Lee, J., Azzaroli, F., Wang, L., Soroka, C.J., Gigliozzi, A., Setchell, K.D. et al. (2001) Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology, 121 (6), 1473-84.
24. Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P.J., Hirose, K. et al. (2000) Characterization of inducible nature of MRP3 in rat liver. Am J Physiol, 278, 438-46.
25. Hirohashi, T., Suzuki, H. and Sugiyama, Y. (1999) Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem, 274, 15181-185.
26. Kruh, G.D., Belinsky, M.G., Gallo, J.M. and Lee, K. (2007) Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer Metastasis Rev, 26 (1), 5-14.
27. Zamek-Gliszczynski, M.J., Hoffmaster, K.A., Nezasa, K., Tallman, M.N. and Brouwer, K.L. (2006) Integration of hepatic drug transporters and Phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci, 27 (5), 447-86.
28. Takikawa, H., Beppu, T. and Seyama, Y. (1984) Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases. Gastroenterol Jpn, 19 (2), 104-9.
29. Lee, J.M., Azzaroli, F., Gigliozzi, A., Mennone, A. and Boyer, J.L. (1999) Adaptive regulation of the ileal sodium-dependent bile salt transporter (ISBT), and the multispecific organic anion transporter (MRP2), in kidney and cholangiocytes in chronic cholestasis - alternative pathways for bile salt excretion. Hepatology, 30, 417A.
30. Sauer, P., Stiehl, A., Fitscher, B.A., Hans-Dieter, R., Benz, C., Klöters-Plachky, P. et al. (2000) Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J Hepatol, 33, 2-8.
31. Hruz, P., Zimmermann, C., Gutmann, H., Degen, L., Beuers, U., Terracciano, L. et al. (2006) Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut, 55 (3), 395-402.
32. Villanueva, S.S., Ruiz, M.L., Soroka, C.J., Cai, S.Y., Luquita, M.G., Torres, A.M. et al. (2006) Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats.1. Drug Metab Dispos, 34 (8), 1301-9.
33. Dietrich, C.G., Geier, A., Salein, N., Lammert, F., Roeb, E., Oude Elferink, R.P. et al. (2004) Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology, 126 (4), 1044-53.
34. Karpen, S.J. (1999) Bile acids go nuclear! Hepatology, 30, 1107-9.
35. Cai, S.Y. and Boyer, J.L. (2006) FXR: a target for cholestatic syndromes? 1. Expert Opin Ther Targets, 10 (3), 409-21.
36. Pellicciari, R., Costantino, G. and Fiorucci, S. (2005) Farnesoid X receptor: from structure to potential clinical applications. J Med Chem, 48 (17), 5383-403.
37. Guo, G.L., Lambert, G., Negishi, M., Ward, J.M., Brewer, H.B. Jr, Kliewer, S.A. et al. (2003) Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem, 278, 45062-71.
38. Trottier, J., Milkiewicz, P., Kaeding, J., Verreault, M. and Barbier, O. (2006) Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol Pharm, 3 (3), 212-22.
39. Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S. et al. (2003) Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol, 39, 480-88.
40. Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O. et al. (2003) Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology, 125, 825-38.
41. Stedman, C.A., Liddle, C., Coulter, S.A., Sonoda, J., Alvarez, J.G., Moore, D.D. et al. (2005) Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci U S A, 102 (6), 2063-68.
42. Uppal, H., Toma, D., Saini, S.P., Ren, S., Jones, T.J. and Xie, W. (2005) Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice. Hepatology, 41 (1), 168-76.
43. Uppal, H., Saini, S.P., Moschetta, A., Mu, Y., Zhou, J. and Gong, H. et al. (2007) Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology, 45 (2), 422-32.
44. Ohata, M., Lin, M., Satre, M. and Tsukamoto, H. (1997) Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol, 272 (3Pt 1), 589-96.
45. Zimmerman, T.L., Thevananther, S., Ghose, R., Burns, A.R. and Karpen, S.J. (2006) Nuclear export of retinoid X receptor alpha in response to interleukin-1β-mediated cell signaling: roles for JNK and SER260.1. J Biol Chem, 281 (22), 15434-40.
46. Demeilliers, C., Jacquemin, E., Barbu, V., Mergey, M., Paye, F. and Fouassier, L. et al. (2006) Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation. 1. Hepatology, 43 (5), 1125-34.
47. Chen, H.L., Liu, Y.J., Chen, H.L., Wu, S.H., Ni, Y.H., Ho, M.C. et al. (2008) Expression of hepatocyte transporters and nuclear receptors in children with early- and late-stage biliary atresia. Pediatr Res 63 (6), 667-73.
48. Cindoruk, M., Kerem, M., Karakan, T., Salman, B., Akin, O., Alper, M. et al. (2007) Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study. BMC Gastroenterol, 7, 44.
49. Iwasaki, S., Ohira, H., Nishiguchi, S., Zeniya, M., Kaneko, S. and Onji, M. et al. (2008) The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study. Hepatol Res, 38 (6), 557-64.
50. Walker, L.J., Newton, J., Jones, D.E.J. and Bassedine, M.F. (2009) Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in Primary Biliary Cirrhosis. 49, 337.
51. Jung, D. and Kullak-Ublick, G.-A. (2003) Hepatocyte nuclear factor 1a: a key mediator of the effect of bile acids on gene expression. Hepatology, 37, 622-31.
52. Zollner, G., Marschall, H.U., Wagner, M. and Trauner, M. (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm, 3 (3), 231-51.
53. Gartung, C., Ananthanarayanan, M., Rahman, M.A., Schuele, S., Nundy, S., Soroka, C.J. et al. (1996) Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology, 110, 199-209.
54. Landmann, L., Angermuller, S., Rahner, C. and Stieger, B. (1998) Expression, distribution, and activity of Na+, K+-ATPase in normal and cholestatic rat liver. J Histochem Cytochem, 46 (3), 405-10.
55. Moseley, R.H., Wang, W., Takeda, H., Lown, K., Shick, L., Ananthanarayanan, M. et al. (1996) Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol, 271, 137-46.
56. Simon, F.R., Fortune, J., Iwahashi, M., Gartung, C., Wolkoff, A. and Sutherland, E. (1996) Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol, 271, 1043-52.
57. Green, R.M., Beier, D. and Gollan, J.L. (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology, 111, 193-98.
58. Elsing, C., Reichen, J., Marti, U. and Renner, E.L. (1994) Hepatocellular Na+/H+ exchange is activated at transcriptional and posttranscriptional levels in rat biliary cirrhosis. Gastroenterology, 107, 468-78.
59. Zollner, G., Fickert, P., Zenz, R., Fuchsbichler, A., Stumptner, C., Kenner, L. et al. (2001) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology, 33, 633-46.
60. Ubl, J., Murer, H. and Kolb, H.-A. (1988) Ion channels activated by osmotic and mechanical stress in membranes of opossum kidney cells. J Membr Biol, 104, 223-32.
61. Trauner, M., Arrese, M., Lee, H., Boyer, J.L. and Karpen, S. (1998) Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest, 101, 2092-100.
62. Shneider, B.L., Fox, V.L., Schwarz, K.B., Watson, C.L., Ananthanarayanan, M., Thevananther, S. et al. (1997) Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology, 25, 1176-83.
63. Elferink, M.G., Olinga, P., Draaisma, A.L., Merema, M.T., Faber, K.N., Slooff, M.J. et al. (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol, 287 (5), G1008-16.
64. Gartung, C., Schuele, S., Schlosser, S.F. and Boyer, J.L. (1997) Expression of the rat liver Na+/taurocholate cotransporter is regulated in vivo by retention of biliary constituents but not their depletion. Hepatology, 25, 284-90.
65. Jung, D., Hagenbuch, B., Fried, M., Meier, P.J. and Kullak-Ublick, G.A. (2004) Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol, 286 (5), 752-61.
66. Geier, A., Martin, I.V., Dietrich, C.G., Balasubramaniyan, N., Strauch, S., Suchy, F.J. et al. (2008) Hepatocyte nuclear factor-4α is a central transactivator of the mouse Ntcp gene. Am J Physiol Gastrointest Liver Physiol, 295 (2), 226-33.
67. Eloranta, J.J., Jung, D. and Kullak-Ublick, G.A. (2006) The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1α, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Mol Endocrinol, 20 (1), 65-79.
68. Karpen, S.J., Sun, A., Kudish, B., Hagenbuch, B., Meier, P.J., Ananthanarayanan, M. et al. (1996) Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem, 271, 15211-21.
69. Denson, L.A., Auld, K.L., Schiek, D.S., McClure, M.H., Mangelsdorf, D.J. and Karpen, S.J. (2000) Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem, 275, 8835-43.
70. Ganguly, T.C., O’Brien, M.L., Karpen, S.J., Hyde, J.F., Suchy, F.J. and Vore, M. (1997) Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. J Clin Invest, 99, 2906-14.
71. Denson, L.A., Sturm, E., Echevarria, W., Zimmerman, T.L., Makishima, M., Mangelsdorf, D.J. et al. (2001) The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology, 121, 140-47.
72. Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Stumptner, C., Zatloukal, K. et al. (2002) Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol, 282 (1), 184-91.
73. Zollner, G., Wagner, M., Fickert, P., Geier, A., Fuchsbichler, A., Silbert, D. et al. (2005) Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiol Gastrointest Liver Physiol, 289 (5), 798-805.
74. Gartung, C., Trauner, M., Schlosser, S.F., Hagenbuch, B., Meier, P.J. and Boyer, J.L. (1996) Sodium-independent uptake of bile acids is unaffected by down-regulation of an organic anion transporter (oatp) in rat liver during cholestasis produced by common bile duct ligation (CBDL). Hepatology, 24, 369A.
75. Geier, A., Dietrich, C.G., Trauner, M. and Gartung, C. (2007) Extrahepatic cholestasis downregulates Oatp1 by TNF-α signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver. Liver Int, 27 (8), 1056-65.
76. Kullak-Ublick, G.-A., Beuers, U., Fahney, C., Hagenbuch, B., Meier, P.J. and Paumgartner, G. (1997) Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology, 26, 991-97.
77. Jung, D., Podvinec, M., Meyer, U.A., Mangelsdorf, D.J., Fried, M., Meier, P.J. et al. (2002) Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology, 122, 1954-66.
78. Kullak-Ublick, G.-A., Hagenbuch, B., Stieger, B., Wolkoff, A.W. and Meier, P.J. (1994) Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology, 20, 411-16.
79. Kullak-Ublick, G.A., Hagenbuch, B., Stieger, B., Schteingart, C.D., Hofmann, A.F., Wolkoff, A.W. et al. (1995) Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology, 109, 1274-82.
80. Eckhardt, U., Schroeder, A., Stieger, B., Hochli, M., Landmann, L., Tynes, R. et al. (1999) Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably tranfected CHO cells. Am J Physiol, 276, 1037-42.
81. Abe, T., Kakyo, M., Tokui, T., Nakagomi, R., Nishio, T., Nakai, D. et al. (1999) Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem, 274, 17159-63.
82. Reichel, C., Gao, B., Van Montfoort, J., Cattori, V., Rahner, C., Hagenbuch, B. et al. (1999) Localization and function of the organic anion-transporting polypeptide oatp2 in rat liver. Gastroenterology, 117, 688-95.
83. Kakyo, M., Unno, M., Tokui, T., Nakagomi, R., Nishio, T., Iwasashi, H. et al. (1999) Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1. Gastroenterology, 117, 770-75.
84. Kullak-Ublick, G.-A., Fisch, T., Oswald, M., Hagenbuch, B., Meier, P.J., Beuers, U. et al. (1998) Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain. FEBS Lett, 424, 173-76.
85. Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.P. et al. (1999) A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem, 274, 37161-68.
86. Konig, J., Cui, Y., Nies, A.T. and Keppler, D. (2000) A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol, 278, 156-64.
87. Hagenbuch, B. and Gui, C. (2008) Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica, 38 (7), 778-801.
88. Li, L., Lee, T.K., Meier, P.J. and Ballatori, N. (1998) Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J Biol Chem, 273, 16184-91.
89. Satlin, L.M., Amin, V. and Wolkoff, A.W. (1997) Organic anion transporting polypeptide mediates organic anion/HCO3-exchange. J Biol Chem, 272, 26340-45.
90. Lee, W., Glaeser, H., Smith, L.H., Roberts, R.L., Moeckel, G.W., Gervasini, G. et al. (2005) Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem, 280 (10), 9610-17.
91. Donner, M.G., Schumacher, S., Warskulat, U., Heinemann, J. and Haussinger, D. (2007) Obstructive cholestasis induces TNF-α- and IL-1-mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. Am J Physiol Gastrointest Liver Physiol, 293 (6), 1134-46.
92. Gartung, C. and Matern, S. (1998) Molecular regulation of organic anion transport in cholestasis. In: Falk Symposium 102: Cholestatic Liver Diseases (eds M. Manns, J.L. Boyer, P.L.M. Jansen and J. Reichen), Kluwer Academic Publishers, Dordrecht, pp. 21-28.
93. Green, R.M., Gollan, J.L., Hagenbuch, B., Meier, P.J. and Beier, D.R. (1997) Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol, 273, 621-27.
94. Geier, A., Dietrich, C.G., Gerloff, T., Kullak-Ublick, G.-A., Steiger, B., Meier, P.J. et al. (2003) Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim Biophys Acta, 1609, 87-94.
95. Geier, A., Dietrich, C.G., Voigt, S., Kim, S.-K., Gerloff, T., Kullak-Ublick, G.-A. et al. (2003) Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology, 38, 345-54.
96. Denk, G.U., Soroka, C.J., Mennone, A., Koepsell, H., Beuers, U. and Boyer, J.L. (2004) Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology, 39 (5), 1382-89.
97. Cherrington, N.J., Slitt, A.L., Li, N. and Klaassen, C.D. (2004) Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos, 32 (7), 734-41.
98. Saborowski, M., Kullak-Ublick, G.A. and Eloranta, J.J. (2006) The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4α. J Pharmacol Exp Ther, 317 (2), 778-85.
99. Brandoni, A., Villar, S.R., Picena, J.C., Anzai, N., Endou, H. and Torres, A.M. (2006) Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction. Hepatology, 43 (5), 1092-100.
100. Hofmann, A.F. and Hagey, L.R. (2008) Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci, 65 (16), 2461-83.
101. Goodwin, B., Jones, S.A., Price, R.R., Watson, M.A., McKee, D.D., Moore, L.B. et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell, 6, 517-26.
102. Lin, B.C., Wang, M., Blackmore, C. and Desnoyers, L.R. (2007) Liver-specific activities of FGF19 require klotho beta. J Biol Chem, 282 (37), 27277-84.
103. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C.L., McDonald, J.G. et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab, 2 (4), 217-25.
104. Holt, J.A., Luo, G., Billin, A.N., Bisi, J., McNeill, Y.Y., Kozarsky, K.F. et al. (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev, 17 (13), 1581-91.
105. Schaap, F.G., van deer Gaag, N.A., Gouma, D.J. and Jansen, P.L. (2009) High expression of the bile salt homeostatic hormone fibroblast growth factor 19 in the liver of the patients with extraheptic cholestasis. Hepatology, 49 (4), 1228-1235.
106. De Fabiani, E., Mitro, N., Anzulovich, A.C., Pinelli, A., Galli, G. and Crestani, M. (2001) The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem, 276, 30708-16.
107. Gupta, S., Stravitz, R.T., Dent, P. and Hylemon, P.B. (2001) Down-regulation of cholesterol 7α-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem, 276, 15816-22.
108. Li, T., Jahan, A. and Chiang, J.Y. (2006) Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology, 43 (6), 1202-10.
109. Rao, A., Haywood, J., Craddock, A.L., Belinsky, M.G., Kruh, G.D. and Dawson, P.A. (2008) The organic solute transporter alpha-beta, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis. Proc Natl Acad Sci U S A, 105 (10), 3891-96.
110. Ballatori, N., Fang, F., Christian, W.V., Li, N. and Hammond, C.L. (2008) Ostα-Ostβ is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. Am J Physiol Gastrointest Liver Physiol, 295 (1), 179-86.
111. Kim, I., Ahn, S.H., Inagaki, T., Choi, M., Ito, S., Guo, G.L. (2007) et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res, 48 (12), 2664-72.
112. Sinha, J., Chen, F., Miloh, T., Burns, R.C., Yu, Z. and Shneider, B.L. (2008) β-Klotho and FGF 15/19 inhibit the apical sodium dependent bile acid transporter in enterocytes and cholangiocytes. Am J Physiol Gastrointest Liver Physiol 295 (5), G996-1003.
113. Li, T. and Chiang, J.Y. (2007) A novel role of transforming growth factor beta1 in transcriptional repression of human cholesterol 7α-hydroxylase gene. Gastroenterology, 133 (5), 1660-69.
114. Song, K.H., Ellis, E., Strom, S. and Chiang, J.Y. (2007) Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes. Hepatology, 46 (6), 1993-2002.
115. Liu, Y., Binz, J., Numerick, M.J., Dennis, S., Luo, G., Desai, B. et al. (2003) Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest, 112 (11), 1678-87.
116. Koopen, N.R., Post, S.M., Wolters, H., Havinga, R., Stellaard, F., Boverhof, R. et al. (1999) Differential effects of 17α-ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat. J Lipid Res, 40 (1), 100-8.
117. Chen, J. and Farrell, G.C. (1996) Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastroenterol Hepatol, 11, 870-77.
118. Marschall, H.U., Wagner, M., Bodin, K., Zollner, G., Fickert, P., Gumhold, J. et al. (2006) Fxr(-/-) mice adapt to biliary obstruction by enhanced Phase I detoxification and renal elimination of bile acids. J Lipid Res, 47 (3), 582-92.
119. Stedman, C., Robertson, G., Coulter, S. and Liddle, C. (2004) Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J Biol Chem, 279 (12), 11336-43.
120. Saini, S.P., Sonoda, J., Xu, L., Toma, D., Uppal, H., Mu, Y. et al. (2004) A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol, 65 (2), 292-300.
121. Miyata, M., Matsuda, Y., Tsuchiya, H., Kitada, H., Akase, T., Shimada, M. et al. (2006) Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase. Drug Metab Pharmacokinet, 21 (4), 315-23.
122. Chen, Y.H., Hong, I.C., Kuo, K.K., Hsu, H.K. and Hsu, C. (2007) Role of retinoid-X receptor-alpha in the suppression of rat bile acid coenzyme A-amino acid N-acyltransferase in liver during sepsis. Shock, 28 (1), 65-70.
123. Carlton, V.E., Harris, B.Z., Puffenberger, E.G., Batta, A.K., Knisely, A.S., Robinson, D.L. et al. (2003) Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet, 34, 91-96.
124. Konig, J., Nies, A.T., Cui, Y., Leier, I. and Keppler, D. (1999) Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta, 1461, 377-94.
125. Borst, P., Evers, R., Kool, M. and Wijnholds, J. (1999) The multidrug resistance protein family. Biochim Biophys Acta, 1461, 347-57.
126. Frohling, W. and Stiehl, A. (1976) Bile salt glucuronides: identification and quantitative analysis in the urine of patients with cholestasis. Eur J Clin Invest, 6 (1), 67-74.
127. Makino, I., Hashimoto, H., Shinozaki, K., Yoshino, K. and Nakagawa, S. (1975) Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases. Gastroenterology, 68 (3), 545-53.
128. Bohan, A., Chen, W.S., Denson, L.A., Held, M.A. and Boyer, J.L. (2003) Tumor necrosis factor alphadependent up-regulation of Lrh-1 and Mrp3 (Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem, 278 (38), 36688-98.
129. Chen, W., Cai, S.Y., Xu, S., Denson, L.A., Soroka, C.J. and Boyer, J.L. (2007) Nuclear receptors RXRalpha: RARalpha are repressors for human MRP3 expression. Am J Physiol Gastrointest Liver Physiol, 292 (5), 1221-27.
130. Belinsky, M.G., Dawson, Pa., Shchaveleva, I., Bain, L.J., Wang, R., Ling, V. et al. (2005) Analysis of the in vivo functions of Mrp3. Mol Pharmacol, 68 (1), 160-68.
131. Zelcer, N., van de Wetering, K., de Waart, R., Scheffer, G.L., Marschall, H.U., Wielinga, P.R. et al. (2006) Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol, 44 (4), 768-75.
132. Lickteig, A.J., Slitt, A.L., Arkan, M.C., Karin, M. and Cherrington, N.J. (2007) Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1β, interleukin-6, and nuclear factor-κB in two models of cholestasis. Drug Metab Dispos, 35 (3), 402-9.
133. Huang, W., Zhang, Z., Chua, S.S., Qatanani, M., Han, Y., Granata, R. et al. (2003) Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A, 100, 4156-61.
134. Maher, J.M., Cherrington, N.J., Slitt, A.L. and Klaassen, C.D. (2006) Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. Life Sci, 78 (19), 2219-25.
135. Landrier, J.F., Eloranta, J.J., Vavricka, S.R. and Kullak-Ublick, G.A. (2005) The nuclear receptor for bile acids, FXR, transactivates the human organic solute transporter-alpha and -beta genes. Am J Physiol Gastrointest Liver Physiol, 290, 476-85.
136. Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J. et al. (2006) Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol, 290 (5), 923-32.
137. Okuwaki, M., Takada, T., Iwayanagi, Y., Koh, S., Kariya, Y., Fujii, H. et al. (2007) LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR. Pharm Res, 24 (2), 390-98.
138. Trauner, M., Arrese, M., Soroka, C., Ananthanarayanan, M., Koeppel, T.A., Schlosser, S.F. et al. (1997) The rat canalicular conjugate export pump (mrp 2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology, 113, 255-64.
139. Kagawa, T., Watanabe, N., Sato, M., Nakano, A., Nishizaki, Y., Hosoi, K. et al. (1998) Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats. Biochem Mol Biol Int, 44, 443-52.
140. Lam, P., Wang, R. and Ling, V. (2005) Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. Biochemistry, 44 (37), 12598-605.
141. Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N. et al. (2003) NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22 (1), 90-97.
142. Cerveny, L., Svecova, L., Anzenbacherova, E., Vrzal, R., Staud, F., Dvorak, Z. et al. (2007) Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos, 35 (7), 1032-41.
143. Geick, A., Eichelbaum, M. and Burk, O. (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem, 276 (18), 14581-87.
144. Maeda, K. and Sugiyama, Y. (2008) Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab Pharmacokinet, 23 (4), 223-35.
145. Deleuze, J.F., Jacquemin, E., Dubuisson, C., Crestell, D., Dumont, M., Erlinger, S. et al. (1996) Defect on multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology, 23, 904-8.
146. Smit, J.J.M., Schinkel, A.H., Oude Elferink, R.P.J., Groen, A.K., Wagenaar, E., Vendeemter, L. et al. (1993) Homozygous disruption of the murine mdr2P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 75, 451-62.
147. Mauad, T.H., van Nieuwkerk, C.M.J., Dingemans, K.P., Smit, J.J.M., Schinkel, A.H., Notenboom, R.G.E. et al. (1994) Mice with homozygous disruption of the mdr2 p-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol, 145, 1237-45.
148. Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H. et al. (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology, 127 (1), 261-74.
149. Trauner, M., Fickert, P. and Wagner, M. (2007) MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis, 27 (1), 77-98.
150. Oude Elferink, R.P.J., Ottenhoff, R., van Wijland, M., Smit, J.J.M., Schinkel, A.H. and Groen, A.K. (1995) Regulation of biliary lipid secretion by mdr2P-glycoprotein in the mouse. J Clin Invest, 95, 31-38.
151. Oude Elferink, R.P.J. and Groen, A.K. (1995) The role of mdr2P-glycoprotein in biliary lipid secretion. Cross-talk between cancer research and biliary physiology. J Hepatol, 23, 617-25.
152. Oude Elferink, R.P.J., Tytgat, G.N.J. and Groen, A.K. (1997) The role of mdr2P-glycoprotein in hepatobiliary lipid transport. FASEB J, 11, 19-28.
153. Bull, L.N., Carlton, V.E.H., Stricker, N.L., Baharloo, S., DeYoung, J.A., Freimer, N.B. et al. (1997) Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology, 26, 155-64.
154. De Vree, J.M., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P.J., Aten, J. et al. (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A, 95 (1), 282-87.
155. Jacquemin, E., Cresteil, D., Manouvrier, S., Boute, O. and Hadchouel, M. (1999) Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet, 353, 210-11.
156. Schneider, G., Paus, T.C., Kullak-Ublick, G.A., Meier, P.J., Wienker, T.F., Lang, T. et al. (2007) Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology, 45 (1), 150-58.
157. Pauli-Magnus, C., Lang, T., Meier, Y., Zodan-Marin, T., Jung, D., Breymann, C. et al. (2004) Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics, 14 (2), 91-102.
158. Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R. et al. (2007) Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics, 17 (1), 47-60.
159. Gotthardt, D., Runz, H., Keitel, V., Fischer, C., Flechtenmacher, C., Wirtenberger, M. et al. (2008) A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults. Hepatology 48 (4), 1157-66.
160. Huang, L., Zhao, A., Lew, J.L., Zhang, T., Hrywna, Y., Thompson, J.R. et al. (2003) Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem, 278 (51), 51085-90.
161. Oude Elferink, R.P. and Paulusma, C.C. (2007) Function and pathophysiological importance of ABCB4 (MDR3P-glycoprotein). Pflugers Arch, 453 (5), 601-10.
162. Meier, Y., Pauli-Magnus, C., Zanger, U.M., Klein, K., Schaeffeler, E., Nussler, A.K. et al. (2006) Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology, 44 (1), 62-74.
163. Niemi, M., Arnold, K.A., Backman, J.T., Pasanen, M.K., Godtel-Armbrust, U., Wojnowski, L. et al. (2006) Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet Genomics, 16 (11), 801-8.
164. Buechler, M., Koenig, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T. et al. (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem, 271, 15091-98.
165. Ito, K., Suzuki, H., Hirohashi, T., Kazuhiko, K., Shimizu, T. and Sugiyama, Y. (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol, 272, 16-22.
166. Kartenbeck, J., Leuschner, U., Mayer, R. and Keppler, D. (1996) Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology, 23, 1061-66.
167. Paulusma, C.C., Kool, M., Bosma, P.J., Scheffer, G.L., ter Borg, F., Scheper, R.J. et al. (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology, 25, 1539-42.
168. Wada, M., Toh, S., Taniguchi, K., Nakamura, T., Uchiumi, T., Kohno, K. et al. (1998) Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet, 7, 203-7.
169. Oude Elferink, R.P.J., Ottenhoff, R., Liefting, W., Haan, J.D. and Jansen, P.L.M. (1989) Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. J Clin Invest, 84, 478-83.
170. Paulusma, C., van Geer, M., Evers, R., Heijn, M., Ottenhoff, R., Borst, P. et al. (1999) Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J, 338, 393-401.
171. Ballatori, N. and Truong, A.T. (1989) Relation between biliary glutathione excretion and bile acid-independent bile flow. Am J Physiol, 256, 22-30.
172. Daly, A.K., Aithal, G.P., Leathart, J.B., Swainsbury, R.A., Dang, T.S. and Day, C.P. (2007) Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology, 132 (1), 272-81.
173. Choi, J.H., Ahn, B.M., Yi, J., Lee, J.H., Lee, J.H., Nam, S.W. et al. (2007) MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics, 17 (6), 403-15.
174. Koopen, N.R., Wolters, H., Havinga, R., Vonk, R.J., Jansen, P.L.M., Müller, M. et al. (1998) Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat. Hepatology, 27, 537-45.
175. Lee, J.M., Trauner, M., Soroka, C.J., Stieger, B., Meier, P.J. and Boyer, J.L. (2000) Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology, 118, 163-72.
176. Kubitz, R., Wettstein, M., Warskulat, U. and Haussinger, D. (1999) Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology, 116, 401-10.
177. Paulusma, C., Kothe, M.J.C., Bakker, C.T.M., Bosma, P.J., van Bokhoven, I., Van Marle, J. et al. (2000) Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology, 31, 684-93.
178. Rost, D., Kartenbeck, J. and Keppler, D. (1999) Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology, 29, 814-21.
179. Maher, J.M., Dieter, M.Z., Aleksunes, L.M., Slitt, A.L., Guo, G., Tanaka, Y. et al. (2007) Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology, 46 (5), 1597-610.
180. Ollinger, R., Wang, H., Yamashita, K., Wegiel, B., Thomas, M., Margreiter, R. et al. (2007) Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal, 9 (12), 2175-85.
181. Strautnieks, S.S., Kagalwalla, A.F., Tanner, M.S., Knisely, A.S., Ball, L., Freimer, N. et al. (1997) Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet, 61, 630-33.
182. Strautnieks, S.S., Bull, L., Knisely, A.S., Kocoshis, S.A., Dahl, N., Arnell, H. et al. (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet, 20, 233-38.
183. Strautnieks, S.S., Byrne, J.A., Pawlikowska, L., Cebecauerova, D., Rayner, A., Dutton, L. et al. (2008) Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology, 134 (4), 1203-14.
184. Jansen, P.L., Strautnieks, S.S., Jacquemin, E., Hadchouel, M., Sokal, E.M., Hooiveld, G.J. et al. (1999) Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology, 117, 1370-79.
185. Wang, R., Lam, P., Liu, L., Forrest, D., Yousef, I.M., Mignault, D. et al. (2003) Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein. Hepatology, 38 (6), 1489-99.
186. Bolder, U., Huong-Thu, T., Schteingart, C.D., Frick, E. and Hofmann, A.F. (1997) Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology, 112, 214-25.
187. Bossard, R., Stieger, B., O’Neill, B., Fricker, G. and Meier, P.J. (1993) Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest, 91, 2714-20.
188. Boehme, M., Mueller, M., Leier, I., Jedlitschky, G. and Keppler, D. (1994) Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology, 107, 255-65.
189. Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G.-A. and Meier, P.J. (2000) Drug-and estrogeninduced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology, 118, 422-30.
190. Kogan, D., Ananthanarayanan, M., Emre, S., Suchy, F.J. and Shneider, B.L. (1999) The bile salt excretory pump (BSEP/SPGP) is not down-regulated in human cholestasis associated with extrahepatic biliary atresia (EHBA). Hepatology, 30, 468A.
191. Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D.J. and Suchy, F.J. (2001) Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem, 276, 28857-65.
192. Gerloff, T., Geier, A., Roots, I., Meier, P.J. and Gartung, C. (2002) Functional analysis of the rat bile salt export pump gene promoter. Eur J Biochem, 269 (14), 3495-503.
193. Plass, J.R.M., Mol., O., Heegsma, J., Geuken, M., Faber, K.N., Jansen, P.L.M., Farnesoid, X. et al. (2002) Receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology, 35 (3), 589-96.
194. Sinal, C.J., Tohkin, M., Miyata, M., Ward, J.M., Lambert, G. and Gonzalez, F.J. (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell, 102, 731-44.
195. Song, X., Kaimal, R., Yan, B. and Deng, R. (2008) Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression. J Lipid Res, 49 (5), 973-84.
196. Meier, Y., Zodan, T., Lang, C., Zimmermann, R., Kullak-Ublick, G.A., Meier, P.J. et al. (2008) Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T > C polymorphism in the bile salt export pump. World J Gastroenterol, 14 (1), 38-45.
197. van Herwaarden, A.E. and Schinkel, A.H. (2006) The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.1. Trends Pharmacol Sci, 27 (1), 10-16.
198. Suzuki, M., Suzuki, H., Sugimoto, Y. and Sugiyama, Y. (2003) ABCG2 transports sulfated conjugates of steroids and xenobiotics.1. J Biol Chem, 278 (25), 22644-49.
199. Zimmermann, C., Hruz, P., Gutmann, H., Terracciano, L., Beuers, U., Lehmann, F. et al. (2006) Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis. Digestion, 74 (2), 101-8.
200. Enokizono, J., Kusuhara, H. and Sugiyama, Y. (2007) Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect. Drug Metab Dispos, 35 (2), 209-14.
201. Graf, G.A., Yu, L., Li, W.P., Gerard, R., Tuma, P.L., Cohen, J.C. et al. (2003) ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem, 278 (48), 48275-82.
202. Kamisako, T. and Ogawa, H. (2005) Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. J Gastroenterol Hepatol, 20 (9), 1429-34.
203. Moriyama, Y., Hiasa, M., Matsumoto, T. and Omote, H. (2008) Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. Xenobiotica, 38 (7), 1107-18.
204. Omote, H., Hiasa, M., Matsumoto, T., Otsuka, M. and Moriyama, Y. (2006) The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol Sci, 27 (11), 587-93.
205. Koepsell, H., Lips, K. and Volk, C. (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res, 24 (7), 1227-51.
206. Paulusma, C.C., Groen, A., Kunne, C., Ho-Mok, K.S., Spijkerboer, A.L., Rudi, D.W. et al. (2006) Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology, 44 (1), 195-204.
207. Paulusma, C.C., Folmer, D.E., Ho-Mok, K.S., de Waart, D.R., Hilarius, P.M., Verhoeven, A.J. et al. (2008) ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology, 47 (1), 268-78.
208. Cai, S.Y., Gautam, S., Nguyen, T., Soroka, C.J., Rahner, C. and Boyer, J.L. (2009) ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes but Fxr expression and activity are maintained. Gastroenterology, 136 (3), 1060-1969.
209. Bull, L.N., van Eijk, M.J.T., Pawlikowska, L., DeYoung, J.A., Juijn, J.A., Liao, M. et al. (1998) A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet, 18, 219-24.
210. Boyer, J.L. (1996) Bile duct epithelium: frontiers in transport physiology. Am J Physiol, 270, G1-5.
211. Boyer, J.L. and Nathanson, M.H. (1999) Bile formation. In: Schiff’s Diseases of the Liver (eds E.R. Schiff, M.F. Sorrell and W.C. Maddrey), Lippincott-Raven, Philadelphia, PA, pp. 119-46.
212. Martinez-Anso, E., Castillo, J.E., Diez, J., Medina, J.F. and Prieto, J. (1994) Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology, 19, 1400-6.
213. Prieto, J., Qian, C., Garcia, N., Diez, J. and Medina, J.F. (1993) Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology, 105, 572-78.
214. Medina, J.F., Martinez-Anso, E., Vazquez, J.J. and Prieto, J. (1997) Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology, 25, 12-17.
215. Prieto, J., Garcia, N., Marti-Climent, J.M., Penuelas, I., Richter, J.A. and Medina, J.F. (1999) Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology, 117, 167-72.
216. Vazquez, J.J., Vazquez, M., Idoate, M.A., Montuenga, L., Martinez-Anso, E., Castillo, J.E. et al. (1995) Anion exchanger immunoreactivity in human salivary glands in health and Sjoegren’s syndrome. Am J Pathol, 146, 1422-32.
217. Alvaro, D., Gigliozzi, A., Piat, C., Fraioli, F., Romeo, R., Francia, C. et al. (1997) Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the Cl-/HCO3-exchanger in the rat. J Hepatol, 26, 146-57.
218. Melero, S., Spirli, C., Zsembery, A., Medina, J.F., Joplin, R.E., Duner, E. et al. (2002) Defective regulation of cholangiocyte Cl-/HCO3- and Na+/H+ exchanger activities in primary biliary cirrhosis. Hepatology, 35 (6), 1513-21.
219. Salas, J.T., Banales, J.M., Sarvide, S., Recalde, S., Ferrer, A., Uriarte, I. et al. (2008) Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology, 134 (5), 1482-93.
220. Arenas, F., Hervias, I., Uriz, M., Joplin, R., Prieto, J. and Medina, J.F. (2008) Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. J Clin Invest, 118 (2), 695-709.
221. Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E. and Santucci, L. (2007) Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol Med, 13 (7), 298-309.
222. Beuers, U., Kullak-Ublick, G.A., Pusl, T., Rauws, E.R. and Rust, C. (2009) Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? Clin Rev Allergy Immunol 36 (1), 52-61.